title: Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry.
authors.affiliation: Janssen Pharmaceutica N. V., Beerse, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Thilakarathne
authors.affiliation: Janssen Research & Development, Beerse, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Diels
authors.affiliation: EMEA HEMAR Analytics, Janssen EMEA, Beerse, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: van Sanden
authors.affiliation: Janssen-Cilag AB, Sollentuna, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Liwing
authors.affiliation: Janssen, High Wycombe, UK.
authors.forename: O
authors.initials: O
authors.lastname: Chirita
authors.affiliation: Janssen-Cilag BV, Tilburg, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Van Agthoven
authors.affiliation: Karolinska University Hospital, Solna, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Nahi